4//SEC Filing
Karp Daniel 4
Accession 0001127602-20-005781
CIK 0000875045other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:36 PM ET
Size
13.0 KB
Accession
0001127602-20-005781
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
Karp Daniel
EVP, Corporate Development
Transactions
- Exercise/Conversion
Common Stock
2020-02-12+960→ 1,224.387 total - Tax Payment
Common Stock
2020-02-12$331.76/sh−294$97,537→ 930.387 total - Exercise/Conversion
Restricted Stock Unit
2020-02-12−960→ 5,300 totalExercise: $0.00Exp: 2022-02-12→ Common Stock (960 underlying) - Other
Restricted Stock Unit
2020-02-12−1,126→ 4,174 totalExercise: $0.00Exp: 2022-02-12→ Common Stock (1,126 underlying) - Award
Restricted Stock Unit
2020-02-12+6,030→ 6,030 totalExercise: $0.00Exp: 2023-02-12→ Common Stock (6,030 underlying)
Footnotes (2)
- [F1]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).
- [F2]This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number of shares that vested.
Documents
Issuer
BIOGEN INC.
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001744046
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 6:36 PM ET
- Size
- 13.0 KB